26289-09-8 Usage
Description
Glycerophosphoserine, also known as (2S)-2-Amino-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropanoic Acid, is a L-serine derivative with a 1-glycerophospho group attached to the side-chain hydroxy function. It is an essential compound found in various biological processes and has been identified for its potential applications in the medical and pharmaceutical fields.
Uses
Used in Antioxidant Applications:
Glycerophosphoserine is used as an antioxidant in bamboo leaves, contributing to the plant's defense mechanisms against oxidative stress and promoting overall health and longevity.
Used in Hepatocellular Carcinoma Detection:
In the medical field, glycerophosphoserine serves as a useful tool for screening and identifying hepatitis B-related hepatocellular carcinoma. Its presence in the body can indicate the presence of this specific type of liver cancer, aiding in early diagnosis and treatment.
Used in Pharmaceutical Industry:
Glycerophosphoserine is used as a key compound in the development of new drugs and therapies, particularly in the treatment of various diseases and conditions. Its unique structure and properties make it a valuable asset in the design and synthesis of novel pharmaceutical agents.
Check Digit Verification of cas no
The CAS Registry Mumber 26289-09-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,6,2,8 and 9 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 26289-09:
(7*2)+(6*6)+(5*2)+(4*8)+(3*9)+(2*0)+(1*9)=128
128 % 10 = 8
So 26289-09-8 is a valid CAS Registry Number.
InChI:InChI=1/C6H14NO8P/c7-5(6(10)11)3-15-16(12,13)14-2-4(9)1-8/h4-5,8-9H,1-3,7H2,(H,10,11)(H,12,13)/t4?,5-/m0/s1
26289-09-8Relevant articles and documents
Monoclonal antibody recognizing phosphatidylinositol-3,4-diphosphate
-
, (2008/06/13)
A novel monoclonal antibody that specifically recognizes phosphatidylinositol-3,4-biphosphate (PI-3,4-P2) but does not cross-react with structurally similar phospholipid antigens is advantageous for PI-3,4-P2-specific immunoassay. The gene in the variable regions of the monoclonal antibody has been identified, which enables producing recombinant antibodies.
Combinations of tyrosine, methylating agents, phospholipids, fatty acids, and St. John's Wort for the treatment of mental disturbances
-
, (2008/06/13)
This invention provides therapeutic compositions for the treatment or prevention of mental disturbances such as depressive states and for regulating the level of certain neurotransmitters and thereby improving the function of the central nervous system and cognitive function in humans and other animals. The therapeutic compositions comprise any two or more of tyrosine, one or more methylating agents, one or more phospholipids, one or more fatty acids and St. John's Wort (Hypericum perforatum), whether naturally, synthetically, or semi-synthetically derived. The invention also provides a method of administering these compositions to humans or animals in need thereof.
